Earnings Per Share, Basic in USD/shares of Aptevo Therapeutics Inc. from Q3 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Aptevo Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q3 2016 to Q3 2025.
  • Aptevo Therapeutics Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -2.23 USD/shares, a 99.4% increase year-over-year.
  • Aptevo Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 1.86K USD/shares.
  • Aptevo Therapeutics Inc. annual Earnings Per Share, Basic for 2024 was -87.4 USD/shares, a 3671% decline from 2023.
  • Aptevo Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -2.32 USD/shares, a 248% decline from 2022.
  • Aptevo Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was 1.57 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Aptevo Therapeutics Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.86K -$2 +$356 +99.4% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $1.51K -$8 +$1.23K +99.3% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $276 -$4 +$364 +98.8% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$87 $1.88K +$1.82K +3225% 01 Oct 2024 31 Dec 2024 10-K 14 Feb 2025
Q3 2024 -$1.91K -$358 -$336 -1515% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$1.57K -$1.24K -$1.18K -2193% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 -$387 -$368 -$386 -2219% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$2 $56.40 +$57.40 01 Oct 2023 31 Dec 2023 10-K 14 Feb 2025
Q3 2023 -$59 -$22 -$21 -1377% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$39 -$54 -$60 -1067% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $20.00 $17.40 +$18.90 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 $1.00 -$1 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 -$2 $0 -4.9% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $5.58 +$7.33 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$2 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q3 2021 -$1 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$2 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q3 2019 $0 +$0.39 +70.9% 01 Jul 2019 30 Sep 2019 10-Q 07 Nov 2019
Q3 2018 -$1 -$2 -131% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019
Q2 2018 -$1 $0 -9.43% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2018
Q1 2018 -$1 $0 -31.3% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2018
Q3 2017 $1.77 +$5.32 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$1 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 $0 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q3 2016 -$4 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017

Aptevo Therapeutics Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$87 -$85 -3671% 01 Jan 2024 31 Dec 2024 10-K 14 Feb 2025
2023 -$2 -$4 -248% 01 Jan 2023 31 Dec 2023 10-K 14 Feb 2025
2022 $1.57 +$7.64 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 -$6 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.